Riskpilot← Back to searchSign inGet full accessGBS Konsult AB
ABActiveOrg 5569364747Odengatan 27 Lgh 1501Medical specialists activities · NACE 8622Est. 20131 employees
Revenue 2025
SEK 3,4M
+23% vs 2024
EBITDA margin
-40.7%
+12% vs 2024
Equity ratio
54.3%
Financial strength
Net profit 2025
SEK 4M
+13% vs 2024
| Revenue | SEK 3,4M | +23% |
| EBITDA | SEK -1,4M | +12% |
| Net profit | SEK 4M | +13% |
| Total assets | SEK 8,2M | +6% |
| Equity | SEK 4,4M | -20% |
| Employees | 1 | — |
Legal name
GBS Konsult AB
Org number
5569364747
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
2 juli 2013
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolagets ska bedriva medicinsk konsult inom medicin och medicinsk utbildning samt hanterar mediciner och material och utrusning förknippad till verksamheten.
Address
Odengatan 27 Lgh 1501
Email
georgiosbakouros@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 005 | 2 562 | 3 590 | 2 747 | 3 385 |
| Staff expenses | — | — | — | — | −1 155 |
| EBITDA | −388 | 633 | 635 | −1 567 | −1 378 |
| Depreciation & amort. | −50 | −79 | −110 | −384 | −61 |
| EBIT | −438 | 554 | 525 | −1 951 | −1 439 |
| Net financials | −1 | — | −2 | 6 | 795 |
| Profit before tax | 2 748 | 3 942 | 3 379 | 4 546 | 4 883 |
| Tax | −614 | −819 | −708 | −977 | −856 |
| Net profit | 2 134 | 3 123 | 2 671 | 3 569 | 4 027 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 131 | 7 297 | 6 688 | 7 716 | 8 155 |
| Equity | 2 738 | 3 861 | 3 532 | 5 501 | 4 428 |
| Long-term debt | 569 | 993 | 0 | 0 | 410 |
| Short-term debt | 523 | 1 131 | 801 | 651 | 779 |
| Total debt | 1 092 | 2 124 | 801 | 651 | 1 190 |
EBITDA margin
-40.7%
This company
15.8%
Market median
-358% vs market
20212025
Equity ratio
54.3%
This company
38.2%
Market median
+42% vs market
20212025
Return on equity
90.9%
This company
18.4%
Market median
+394% vs market
20212025
Net profit margin
119.0%
This company
8.1%
Market median
+1369% vs market
20212025
Asset turnover
0.42×
This company
1.12×
Market median
-63% vs market
20212025
Debt / equity
0.84×
This company
0.62×
Market median
+35% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
FM | Audit | 2024 |
| Former (1) | ||
JL Chief Auditor | Chief Auditor | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GBS Konsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Joakim Lindberg | Chief Auditor | 0 companies |
| Filip Manfred Branigan | Audit | 0 companies |
| Athanasia Karafylloudi | Deputy Board Member | 0 companies |
| Georgios Bakouros | Board of Directors | 0 companies |